PROLONGATION OF ALLOGENEIC HEART GRAFT-SURVIVAL IN RATS BY ADMINISTRATION OF A PEPTIDE (AA-75-84) FROM THE ALPHA-1 HELIX OF THE FIRST DOMAIN OF HLA-B7-01

被引:64
作者
CUTURI, MC
JOSIEN, R
DOUILLARD, P
PANNETIER, C
CANTAROVICH, D
SMIT, H
MENORET, S
POULETTY, P
CLAYBERGER, C
SOULILLOU, JP
机构
[1] CHU NANTES,INSERM,U211,UNITE RECH EFFECTEURS LYMPHOCYTAIRES T,F-44035 NANTES,FRANCE
[2] STANFORD UNIV,DEPT CARDIOTHORAC SURG,STANFORD,CA 94305
[3] SANGSTAT MED CORP,MENLO PK,CA
[4] INST PASTEUR,INSERM,U277,F-75724 PARIS,FRANCE
关键词
D O I
10.1097/00007890-199503150-00003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Allospecific T lymphocytes mediate graft rejection through specific, direct or indirect, recognition of processed determinants of foreign MHC class I molecules. Small synthetic peptides derived from highly conserved sequences of the alpha 1 helix of the first domain of certain MHC class I molecules have been shown to inhibit CTL responses in vitro and to prolong graft survival in rats when combined with subtherapeutic doses of cyclosporine. Here, we report that the survival of LEW.1W heart allografts was significantly prolonged when transplanted into congenic LEW.1A recipients treated only with a peptide corresponding to residues 75-84 of the human HLA-B7-01 molecule (B7.75-84) before transplantation. The experimental value for mean survival time (+/-SD) in untreated recipients was 13+/-6 days and in peptide-treated recipients was 42+/-27 days (P<0.002). A total of 64% of treated recipients had a functioning graft at 30 days, while grafts were rejected in all rats belonging to the control group within this time. Within graft-infiltrating leukocytes (GIL) in B7.75-84-treated animals, the proportion of T cells was significantly lower and that of CD5(-)/TCR alpha beta(-)/CD16(-)/CD8(+) and MHC class II+ cells concomitantly increased, as compared with nontreated animals. GIL from B7.75-84-treated animals also exhibited a dramatic decrease (approximate to 70%) of allospecific and spontaneous (NK) cytotoxic activity, whereas their proliferation and IL-2 production were similar in both experimental groups. The IFN-gamma, IL-2, and IL-10 mRNA levels from GIL from peptide-treated recipients were similar to levels of controls, reflecting a state of activation of GIL. Perforin and granzyme A mRNA, the level of which may be modulated parallel to impaired cytotoxic functions, were at similar levels in both experimental groups. These data demonstrate that B7.75-84 significantly prolongs graft survival in LEW.1A rats when given as a single agent and suggests that a specifically decreased cytotoxic response (allospecific and spontaneous) plays a major role.
引用
收藏
页码:661 / 669
页数:9
相关论文
共 33 条
  • [1] Clayberger C., Parham P., Rothbard J., Et al., HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes, Nature, 330, (1987)
  • [2] Olson C.A., Williams L.C., McLaughlin-Taylor E., McMillan M., Creation of H-2 class I epitopes using synthetic peptides: Recognition by alloreactive cytotoxic T lymphocytes, Immunology, 86, (1989)
  • [3] Zavazava N., Hausmann R., Muller-Ruchholtz W., Inhibition of anti-HLA-B7 alloreactive CTL by affinity-purified soluble HLA, Transplantation, 51, (1991)
  • [4] Salter R.D., Benjamin R.J., Wesley P.K., Et al., A binding site for the T-cell co-receptor CD8 on the α<sup>3</sup> domain of HLA-A2, Nature, 345, (1990)
  • [5] Clayberger C., Lyu S.C., Pouletty P., Krensky A.M., Peptides corre sponding to T-cell reeeptor-HLA contact regions inhibit class I-restricted immune responses, Transplant Proc, 25, (1993)
  • [6] Nisco S., Vriens P., Hoyt G., Et al., Induction of allograft tolerance by an HLA class I derived peptide, J Immunol, 152, (1994)
  • [7] Sloan-Lancaster J., Evavold B.D., Allen P.M., Induction of T-cell anergy by altered T-cell receptor ligand on live antigen-presenting cells, Nature, 363, (1993)
  • [8] Evavold B.D., Sloan-Lancaster J., Allen P.M., Tickling the TCR: Selective T-cell functions stimulated by altered peptide ligands, Immunol Today, 14, (1993)
  • [9] Christiansen F.T., Witt C.S., Ciccone E., Et al., Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: Ancestral haplotypes encodes particular NK-defmed haplotypes, J Exp Med, 178, (1993)
  • [10] Moretta A., Vitale M., Bottino C., Et al., P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class-I-protected cells in NK clones displaying different specificities, J Exp Med, 178, (1993)